| Issuer | % of Class | Filed |
|---|---|---|
|
Qualigen Therapeutics, Inc.
13D/A
Amendment 1
QLGN · 74754R103
|
20.0% |
11/19/2025
Event 11/17/2025
|
|
Qualigen Therapeutics, Inc.
13D
QLGN · 74754R103
|
8.0% |
11/12/2025
Event 11/6/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.